Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author FUTSCH, Nicolas
PRATES, Gabriela FMUSP-HC
MAHIEUX, Renaud
CASSEB, Jorge FMUSP-HC
DUTARTRE, Helene
dc.date.issued 2018
dc.identifier.citation VIRUSES-BASEL, v.10, n.12, article ID 691, 17p, 2018
dc.identifier.issn 1999-4915
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/31020
dc.description.abstract Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of a neural chronic inflammation, called HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and of a malignant lymphoproliferation, called the adult T-cell leukemia/lymphoma (ATLL). The mechanisms through which the HTLV-1 induces these diseases are still unclear, but they might rely on immune alterations. HAM/TSP is associated with an impaired production of pro-inflammatory cytokines and chemokines, such as IFN-, TNF-, CXCL9, or CXCL10. ATLL is associated with high levels of IL-10 and TGF-. These immunosuppressive cytokines could promote a protumoral micro-environment. Moreover, HTLV-1 infection impairs the IFN-I production and signaling, and favors the IL-2, IL-4, and IL-6 expression. This contributes both to immune escape and to infected cells proliferation. Here, we review the landscape of cytokine dysregulations induced by HTLV-1 infection and the role of these cytokines in the HTLV-1-associated diseases progression.
dc.description.sponsorship · Ligue Nationale contre le Cancer, equipe labelisee program [EL2013-3Mahieux]
· LabEx Ecofect of the ""Universite de Lyon"" [ANR-11-LABX-0048]
· Conselho Nacional de Pesquisa Tecnologico (CNP) [CNPq 301685/2016-9]
· FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2014/22827-7]
· Ligue contre le Cancer
· CNPq [133783/2018-9]
· Soroptimist groupe de l'Ariege
· ENS-Lyon
dc.language.iso eng
dc.publisher MDPI
dc.relation.ispartof Viruses-Basel
dc.rights openAccess
dc.subject HTLV-1; immune system; HAM/TSP; ATLL; cytokines
dc.subject.other t-cell leukemia; lymphotropic virus type-1; myelopathy/tropical spastic paraparesis; i-associated myelopathy; interferon-alpha treatment; central-nervous-system; nf-kappa-b; cerebrospinal-fluid; dendritic cells; oncoprotein tax
dc.title Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases
dc.type article
dc.rights.holder Copyright MDPI
dc.description.group LIM/56
dc.identifier.doi 10.3390/v10120691
dc.identifier.pmid 30563084
dc.type.category review
dc.type.version publishedVersion
hcfmusp.author PRATES, Gabriela:IMT:
hcfmusp.author CASSEB, Jorge:IMT:DVCIENT-83
hcfmusp.author.external · FUTSCH, Nicolas:Univ Claude Bernard Lyon 1, Equipe Oncogenese Retrovirale, CNRS,ENS Lyon,INSERM,U1111, CIRI,UMR5308,Labex Ecofect,Equipe Labellise FRM, F-69007 Lyon, France
· MAHIEUX, Renaud:Univ Claude Bernard Lyon 1, Equipe Oncogenese Retrovirale, CNRS,ENS Lyon,INSERM,U1111, CIRI,UMR5308,Labex Ecofect,Equipe Labellise FRM, F-69007 Lyon, France
· DUTARTRE, Helene:Univ Claude Bernard Lyon 1, Equipe Oncogenese Retrovirale, CNRS,ENS Lyon,INSERM,U1111, CIRI,UMR5308,Labex Ecofect,Equipe Labellise FRM, F-69007 Lyon, France
hcfmusp.origem.id WOS:000455313100030
hcfmusp.origem.id 2-s2.0-85058296927
hcfmusp.publisher.city BASEL
hcfmusp.publisher.country SWITZERLAND
hcfmusp.relation.reference · Afonso PV, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000205
· Afonso PV, 2007, J IMMUNOL, V179, P2576, DOI 10.4049/jimmunol.179.4.2576
· Alais S, 2015, J VIROL, V89, P10580, DOI 10.1128/JVI.01799-15
· ALI A, 1992, J NEUROL, V239, P270
· Ando H, 2013, BRAIN, V136, P2876, DOI 10.1093/brain/awt183
· Araya N, 2014, J CLIN INVEST, V124, P3431, DOI 10.1172/JCI75250
· Arenas-Ramirez N, 2015, TRENDS IMMUNOL, V36, P763, DOI 10.1016/j.it.2015.10.003
· Arnulf B, 2002, BLOOD, V100, P4129, DOI 10.1182/blood-2001-12-0372
· ARYA SK, 1984, SCIENCE, V223, P1086, DOI 10.1126/science.6320374
· Azakami K, 2009, BLOOD, V114, P3208, DOI 10.1182/blood-2009-02-203042
· Banerjee P, 2007, J VIROL, V81, P1690, DOI 10.1128/JVI.01513-06
· Bangham CRM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.12
· Bangham CRM, 2014, SEMIN CANCER BIOL, V26, P89, DOI 10.1016/j.semcancer.2013.11.003
· Bazarbachi A, 2010, J CLIN ONCOL, V28, P4177, DOI 10.1200/JCO.2010.28.0669
· Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006
· Starling ALB, 2015, BIOMARKERS, V20, P502, DOI 10.3109/1354750X.2015.1094141
· Starling ALB, 2013, ACTA TROP, V125, P75, DOI 10.1016/j.actatropica.2012.09.012
· Brito-Melo GEA, 2007, CLIN EXP IMMUNOL, V147, P35, DOI 10.1111/j.1365-2249.2006.03252.x
· BROWN DA, 1991, EUR J IMMUNOL, V21, P1879, DOI 10.1002/eji.1830210815
· Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240
· Cachat A, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0093-9
· Cachat A, 2013, J VIROL, V87, P13386, DOI 10.1128/JVI.02758-13
· Charoenthongtrakul S, 2011, J VIROL, V85, P6955, DOI 10.1128/JVI.00007-11
· Chaves DG, 2016, J MED VIROL, V88, P1438, DOI 10.1002/jmv.24481
· Chen J, 2010, BLOOD, V116, P5948, DOI 10.1182/blood-2010-04-277418
· Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152
· Cherian MA, 2018, J BIOL CHEM, V293, P6844, DOI 10.1074/jbc.RA117.000164
· Chung HK, 2003, BLOOD, V102, P4130, DOI 10.1182/blood-2003-04-1043
· Colisson R, 2010, BLOOD, V115, P2177, DOI 10.1182/blood-2009-06-224741
· Collins ND, 1999, J VIROL, V73, P9642
· Datta A, 2006, J BIOL CHEM, V281, P23414, DOI 10.1074/jbc.M600684200
· Diani E, 2015, VIROLOGY, V476, P92, DOI 10.1016/j.virol.2014.12.005
· Enose-Akahata Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02563
· Espindola OM, 2015, INTERVIROLOGY, V58, P106, DOI 10.1159/000371766
· Feng X, 2008, VIROLOGY, V374, P210, DOI 10.1016/j.virol.2007.12.036
· Fujimoto T, 1999, INTERNAL MED, V38, P717, DOI 10.2169/internalmedicine.38.717
· Fung MM, 2005, ONCOGENE, V24, P4624, DOI 10.1028/sj.onc.1208507
· Furukawa Y, 2003, J INFECT DIS, V187, P1116, DOI 10.1086/368379
· Furuta R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006722
· Futsch N, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010001
· Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388
· Giam CZ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060161
· Goncalves Denise U., 2008, Inflammation & Allergy Drug Targets, V7, P98, DOI 10.2174/187152808785107642
· Grant C, 2008, BLOOD, V111, P5601, DOI 10.1182/blood-2007-11-123430
· Gupta S, 1999, J EXP MED, V190, P1837, DOI 10.1084/jem.190.12.1837
· Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024
· Hishizawa M, 2004, BRIT J HAEMATOL, V125, P568, DOI 10.1111/j.1365-2141.2004.04956.x
· Hodson A, 2013, HAEMATOLOGICA, V98, P385, DOI 10.3324/haematol.2012.069476
· HOLLSBERG P, 1994, J IMMUNOL, V153, P566
· HORI T, 1986, LEUKEMIA RES, V10, P1447, DOI 10.1016/0145-2126(86)90012-3
· Horiuchi S, 2006, INT J CANCER, V119, P823, DOI 10.1002/ijc.21918
· Huang SS, 2005, J CELL BIOCHEM, V96, P447, DOI 10.1002/jcb.20558
· Huey DD, 2018, COMPARATIVE MED, V68, P4
· Hyun J, 2015, J VIROL, V89, P4880, DOI 10.1128/JVI.02493-14
· IJICHI S, 1995, J NEUROIMMUNOL, V61, P213, DOI 10.1016/0165-5728(95)00101-7
· Inagaki A, 2006, INT J CANCER, V118, P3054, DOI 10.1002/ijc.21688
· ITOYAMA Y, 1988, NEUROLOGY, V38, P1302, DOI 10.1212/WNL.38.8.1302
· Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
· Iwatsuki K, 1995, BRIT J DERMATOL, V133, P861, DOI 10.1111/j.1365-2133.1995.tb06917.x
· Jones KS, 2008, NAT MED, V14, P429, DOI 10.1038/nm1745
· Journo C, 2011, VIRUSES-BASEL, V3, P1374, DOI 10.3390/v3081374
· Kagdi H, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006861
· Kannagi M, 2005, CANCER SCI, V96, P249, DOI 10.1111/j.1349-7006.2005.00050.x
· Kannagi M, 2011, CANCER SCI, V102, P670, DOI 10.1111/j.1349-7006.2011.01862.x
· Kannian P, 2012, J VIROL, V86, P3757, DOI 10.1128/JVI.06900-11
· Kataoka K, 2015, NAT GENET, V47, P1304, DOI 10.1038/ng.3415
· Kchour G, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-91
· KIM SJ, 1990, J EXP MED, V172, P121, DOI 10.1084/jem.172.1.121
· Kinpara S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-52
· Kozako T, 2009, LEUKEMIA, V23, P375, DOI 10.1038/leu.2008.272
· Kozako T, 2006, J IMMUNOL, V177, P5718, DOI 10.4049/jimmunol.177.8.5718
· Kubota R, 2002, J NEUROVIROL, V8, P53, DOI 10.1080/135502802317247811
· Kulkarni A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123196
· KURODA Y, 1992, ACTA NEUROL SCAND, V86, P82, DOI 10.1111/j.1600-0404.1992.tb08059.x
· Lamichhane P, 2017, CANCER RES, V77, P6667, DOI 10.1158/0008-5472.CAN-17-0740
· Lee DK, 2002, J BIOL CHEM, V277, P33766, DOI 10.1074/jbc.M200150200
· LEHKY TJ, 1995, ANN NEUROL, V37, P167, DOI 10.1002/ana.410370206
· LEUNG K, 1988, NATURE, V333, P776, DOI 10.1038/333776a0
· Levin MC, 2001, J NEUROVIROL, V7, P61
· MACCHI B, 1990, PHARMACOL RES, V22, P503, DOI 10.1016/1043-6618(90)90756-4
· Manuel SL, 2013, AIDS RES HUM RETROV, V29, P1273, DOI [10.1089/AID.2013.0054, 10.1089/aid.2013.0054]
· Masaki A, 2018, CANCER SCI, V109, P2383, DOI 10.1111/cas.13654
· Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111
· Matsuura E, 2015, J NEUROPATH EXP NEUR, V74, P2, DOI 10.1097/NEN.0000000000000141
· McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787
· Mendez E, 1997, J VIROL, V71, P9143
· MICALLEF M, 1994, INT J ONCOL, V4, P633
· MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283
· Mitra-Kaushik S, 2004, BLOOD, V104, P3305, DOI 10.1182/blood-2004-01-0266
· Mitre E, 2003, J INFECT DIS, V188, P428, DOI 10.1086/376529
· Montanheiro P, 2007, J NEUROIMMUNOL, V188, P138, DOI 10.1016/j.jneuroim.2007.05.015
· Mori N, 1996, BLOOD, V88, P1035
· MORI N, 1993, EUR J HAEMATOL, V50, P133
· Mori N, 1996, EUR J HAEMATOL, V56, P241
· Mori N, 2001, BLOOD, V97, P2137, DOI 10.1182/blood.V97.7.2137
· Nagai M, 2001, ANN NEUROL, V50, P807, DOI 10.1002/ana.10065
· Nakagawa M, 2018, CANCER CELL, V34, P286, DOI 10.1016/j.ccell.2018.06.014
· NAKAMURA T, 1990, JPN J MED, V29, P362
· Narulla MS, 2017, J VIROL, V91, DOI 10.1128/JVI.00853-17
· NIITSU Y, 1988, BLOOD, V71, P263
· NISHIMOTO N, 1990, J NEUROL SCI, V97, P183, DOI 10.1016/0022-510X(90)90217-B
· Oliere S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001177
· Oliveira PD, 2018, J TROP PEDIATRICS, V64, P151, DOI 10.1093/tropej/fmx039
· OSAME M, 1990, ANN NEUROL, V28, P50, DOI 10.1002/ana.410280110
· Neco HVPD, 2017, AIDS RES HUM RETROV, V33, P1134, DOI [10.1089/aid.2016.0296, 10.1089/AID.2016.0296]
· Rafatpanah H, 2012, J NEUROIMMUNOL, V250, P87, DOI 10.1016/j.jneuroim.2012.05.004
· Ramos JC, 2007, BLOOD, V109, P3060, DOI 10.1182/blood-2006-07-036368
· Rizkallah G, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006353
· Rose-John S, 2004, IMMUNITY, V20, P2, DOI 10.1016/S1074-7613(04)00003-2
· Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002
· Sato T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002479
· Satou Y, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-46
· Sawada L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006597
· Shimauchi T, 2007, INT J CANCER, V121, P2585, DOI 10.1002/ijc.23042
· SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x
· Silbermann K, 2008, J GEN VIROL, V89, P2788, DOI 10.1099/vir.0.2008/003699-0
· Smith D, 1999, VIROLOGY, V257, P314, DOI 10.1006/viro.1999.9679
· Sonar SA, 2017, IMMUNOL CELL BIOL, V95, P843, DOI 10.1038/icb.2017.56
· Suzuki S, 2010, J BIOL CHEM, V285, P4441, DOI 10.1074/jbc.M109.031476
· Sze A, 2013, CELL HOST MICROBE, V14, P422, DOI 10.1016/j.chom.2013.09.009
· Szymocha R, 2000, J NEUROVIROL, V6, P350, DOI 10.3109/13550280009030761
· Takemoto S, 1997, P NATL ACAD SCI USA, V94, P13897, DOI 10.1073/pnas.94.25.13897
· Tarokhian H, 2017, VIRUS RES, V228, P1, DOI 10.1016/j.virusres.2016.11.009
· Tattermusch S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002480
· TENDLER CL, 1990, P NATL ACAD SCI USA, V87, P5218, DOI 10.1073/pnas.87.13.5218
· TENDLER CL, 1991, J CELL BIOCHEM, V46, P302, DOI 10.1002/jcb.240460405
· Tomasello E, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00526
· Toulza F, 2010, J IMMUNOL, V185, P183, DOI 10.4049/jimmunol.0903846
· Toulza F, 2009, INT J CANCER, V125, P2375, DOI 10.1002/ijc.24664
· Tsukasaki Kunihiro, 2012, Leuk Res Treatment, V2012, P101754, DOI 10.1155/2012/101754
· UCHIYAMA T, 1988, BLOOD, V72, P1182
· Uchiyama T, 1997, ANNU REV IMMUNOL, V15, P15, DOI 10.1146/annurev.immunol.15.1.15
· UCHIYAMA T, 1985, J CLIN INVEST, V76, P446, DOI 10.1172/JCI111992
· UMEHARA F, 1993, J NEUROPATH EXP NEUR, V52, P424, DOI 10.1097/00005072-199307000-00010
· Waldele K, 2004, J VIROL, V78, P6081, DOI 10.1128/JVI.78.12.6081-6090.2004
· Wang J, 2017, J IMMUNOL, V199, P2475, DOI 10.4049/jimmunol.1700111
· Wang J, 2017, VIRUS RES, V232, P13, DOI 10.1016/j.virusres.2017.01.016
· Wang TH, 2015, CYTOKINE, V75, P8, DOI 10.1016/j.cyto.2015.04.012
· Yamada Y, 1996, LEUKEMIA LYMPHOMA, V21, P443, DOI 10.3109/10428199609093442
· Yamada Y, 1998, BLOOD, V91, P4265
· Yamamura M, 1998, BRIT J HAEMATOL, V100, P129, DOI 10.1046/j.1365-2141.1998.00538.x
· Yamano Y, 2017, J NEUROIMMUNOL, V304, P51, DOI 10.1016/j.jneuroim.2016.08.012
· Yamasaki K, 1997, J NEUROL SCI, V147, P135, DOI 10.1016/S0022-510X(96)05319-1
· Yang B, 2018, FEBS LETT, V592, P1693, DOI 10.1002/1873-3468.13077
· Yasuma K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005372
· Yuen CK, 2016, J VIROL, V90, P3902, DOI 10.1128/JVI.00129-16
· Zhang J, 2008, VIROLOGY, V379, P306, DOI 10.1016/j.virol.2008.06.035
· Zhang QA, 1999, LEUKEMIA RES, V23, P373, DOI 10.1016/S0145-2126(98)00173-8
· Zhao TJ, 2011, BLOOD, V118, P1865, DOI 10.1182/blood-2010-12-326199
dc.description.index MEDLINE
hcfmusp.citation.scopus 3
hcfmusp.citation.wos 0
hcfmusp.affiliation.country Brasil
hcfmusp.affiliation.country França


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics